Authors
Janna Afanasjeva, PharmD, BCPS is a clinical assistant professor in drug information at the University of Illinois – Chicago College of Pharmacy.
Jalal S. Baig,MD is a medical oncologist at City of Hope Chicago. Baig is board certified in medical oncology, internal medicine and hematology & oncology. Baig's career insterest is in clinical research.
Taymeyah Al-Toubah, MPH, is a senior research project manager at Moffitt Cancer Center.
John E. Sylvester, MD, is a radiation oncologist with GenesisCare.
Kruti Patel, DO, is a medical oncologist, hematologist, and blood marrow transplant and cellular therapy specialist with OHC, a practice in The US Oncology Network.
Tara Graff, DO, MS, earned her undergraduate degree in biology from Elmhurst College where she graduated in 2000. She then obtained her Masters degree from Loyola University in Chicago and earned her Doctor of Osteopathic Medicine credentials from Lake Erie College of Osteopathic Medicine in Bradenton, Florida in 2009.
She completed her residency training in Internal Medicine and a fellowship in Hematology and Oncology at the Medical College of Wisconsin at Froedtert Memorial Lutheran Hospital. She has led several clinical research projects and has published many original oncology and hematology articles.
Dr. Graff recently moved to the Des Moines area and joined Mission Cancer + Blood in August 2014.
Mayra Shanley, PhD, is a principal research scientist at The University of Texas MD Anderson Cancer Center.
Nitika Sharma, MD, is a board-certified and fellowship-trained Medical Oncologist and Hematologist at Cancer Treatment Centers of America, Atlanta.
Zachary Epstein-Peterson, MD, is a lymphoma specialist at Memorial Sloan Kettering Cancer Center in New York, NY.
Lucy Langer, MD is the practice president director of Genetic Risk Evaluation and Testing Compass Oncology , and the medical director of Cancer Genetics atThe US Oncology Network in The Woodlands, Texas.